Drug prices are going up not just because of new innovations in medications, as the pharma industry frequently cites, but also because the industry is pricing existing products higher, according to a Health Affairs study.
Medicare’s Hospital Readmissions Reduction Program (HRRP) has been given a lot of credit for trimming readmission rates, but the real results may be far less impressive, according to a recent study published in Health Affairs.
Consumers are used to getting what they need easily with the click of a button, including ordering and receiving their prescription medications through the mail. But those deliveries may be risky if medicines aren't stored and transported carefully, according to a report from NPR.
The newest bundled payment program is a money-saver for CMS and Medicare, according to a recent study published in the New England Journal of Medicine. The findings are on par with previous studies that revealed other bundles are achieving their goals of lowering healthcare costs and improving care outcomes.
Healthcare stakeholders dealt with a slurry of new regulations, policy shifts and mega deals across the industry in 2018. After a whirlwind of a year, we’ve rounded up our most popular stories from 2018.
The U.S. government has jumped into a False Claims Act lawsuit stemming from a whistleblower against Sutter Health, a healthcare services company based in California, and its affiliate Palo Alto Medical Foundation.